Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Zanichelli

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 19, 2025
Authors' responseAndrea Zanichelli, Walter A Wuillemin, Aleena Banerji, et al.
Vaccines|April 28, 2023
Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA)Roberta Parente, Silvio Sartorio, Luisa Brussino, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 6, 2025
Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidenceAndrea Zanichelli, Walter A Wuillemin, Emel Aygören-Pürsün, et al.
Clinical and Translational Allergy|March 4, 2026
An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema AttacksAleena Banerji, Emel Aygören-Pürsün, Noemi-Anna Bara, et al.
Frontiers in Pharmacology|May 12, 2025
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstatAndrea Zanichelli, Dario Cattaneo, Antonio Gidaro, et al.
Orphanet Journal of Rare Diseases|March 12, 2015
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyAndrea Zanichelli, Francesco Arcoleo, Maria Pina Barca, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 9, 2025
The Impact of COVID-19 on Patients With Bradykinin-Mediated Angioedema in the ITACA CohortRiccardo Senter, Andrea Zanichelli, Agolini Stefano, et al.
The World Allergy Organization Journal|June 23, 2025
Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe'sJonathan A Bernstein, Ignacio Ansotegui, Riccardo Asero, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 19, 2025
Authors' responseAndrea Zanichelli, Walter A Wuillemin, Aleena Banerji, et al.
Vaccines|April 28, 2023
Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA)Roberta Parente, Silvio Sartorio, Luisa Brussino, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 6, 2025
Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidenceAndrea Zanichelli, Walter A Wuillemin, Emel Aygören-Pürsün, et al.
Clinical and Translational Allergy|March 4, 2026
An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema AttacksAleena Banerji, Emel Aygören-Pürsün, Noemi-Anna Bara, et al.
Frontiers in Pharmacology|May 12, 2025
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstatAndrea Zanichelli, Dario Cattaneo, Antonio Gidaro, et al.
Orphanet Journal of Rare Diseases|March 12, 2015
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyAndrea Zanichelli, Francesco Arcoleo, Maria Pina Barca, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 9, 2025
The Impact of COVID-19 on Patients With Bradykinin-Mediated Angioedema in the ITACA CohortRiccardo Senter, Andrea Zanichelli, Agolini Stefano, et al.
The World Allergy Organization Journal|June 23, 2025
Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe'sJonathan A Bernstein, Ignacio Ansotegui, Riccardo Asero, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
Pageof 12